Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer
Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The feeling of shortness of breath is very common in lung cancer. It is uncomfortable for
patients and upsetting for their family. Although drugs like morphine and oxygen can help
some patients feel better, they don't help everybody, and they are not used in patients with
early symptoms. More relief is needed for these patients. The investigators are studying a
drug called tiotropium, which is used in emphysema. It is an inhaler that opens the airways
to allow easier breathing. Every patient will get the drug but also a placebo, in a random
(flip of a coin) order. They will get each for 2 weeks. The investigators will see if they
feel better with the drug.